MbrlCatalogueTitleDetail

Do you wish to reserve the book?
非小细胞肺癌新辅助治疗联合外科治疗的进展
非小细胞肺癌新辅助治疗联合外科治疗的进展
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
非小细胞肺癌新辅助治疗联合外科治疗的进展
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
非小细胞肺癌新辅助治疗联合外科治疗的进展
非小细胞肺癌新辅助治疗联合外科治疗的进展

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
非小细胞肺癌新辅助治疗联合外科治疗的进展
非小细胞肺癌新辅助治疗联合外科治疗的进展
Journal Article

非小细胞肺癌新辅助治疗联合外科治疗的进展

2017
Request Book From Autostore and Choose the Collection Method
Overview
肺癌是世界范围内发病率和死亡率最高的恶性肿瘤。对于可手术切除的IIIa/N2期非小细胞肺癌患者,目前国内外指南均推荐采用手术联合化疗、放疗等多学科治疗模式。最新研究表明,与术后辅助治疗一样,新辅助治疗(化疗或放化疗)可显著改善可切除非小细胞肺癌患者的预后,且在治疗依从性及耐受性方面具有明显优势。非小细胞肺癌新辅助治疗的对象主要是局部进展期病变,特别是临床IIIa/N2期患者,基本治疗模式为术前2-4周期化疗,新辅助治疗后并不增加手术相关的死亡及并发症风险,但是在决定手术时机、入路及切除范围等方面仍面临着挑战。
Publisher
100142 北京,北京大学肿瘤医院暨北京市肿瘤防治研究所胸外二科,恶性肿瘤发病机制及转化研究教育部重点实验室

MBRLCatalogueRelatedBooks